JohnRobertCiottiMD

PubMed

• Quantitative MRI identifies lesional and non-lesional abnormalities in MOGAD.
  Matthew R Brier, Biao Xiang, John R Ciotti, Salim Chahin, Gregory F Wu, Robert T Naismith, Dmitriy Yablonskiy, Anne H Cross> ;Multiple Sclerosis and Related Disorders. 2023 May 1
• 9 citations
  Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series.
  Jeffrey Lambe, Marisa P McGinley, Brandon P Moss, Yang Mao-Draayer, Roman Kassa, John R Ciotti, Sara Mariotto, Amy Kunchok> ;Journal of Neuroimmunology. 2022 Sep 15
• 8 citations
  Perspectives and experiences with COVID-19 vaccines in people with MS.
  John R Ciotti, Dana C Perantie, Brandon P Moss, Kathryn C Fitzgerald, Jeffrey A Cohen, Ellen M Mowry, Robert T Naismith, Salim Chahin> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2022 Mar 7
• 13 citations
  Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-...
  John Robert Ciotti, Noah S Eby, Matthew R. Brier, Gregory F. Wu, Salim Chahin, Anne H. Cross, Robert T. Naismith> ;Multiple Sclerosis. 2021 Apr 19
• 34 citations
  Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica.
  John Robert Ciotti, Noah S Eby, Gregory F. Wu, Robert T. Naismith, Salim Chahin, Anne H. Cross> ;Multiple Sclerosis and Related Disorders. 2020 Oct 1
• 95 citations
  Effects of MS disease-modifying therapies on responses to vaccinations: A review.
  John Robert Ciotti, Manouela V. Valtcheva, Anne H. Cross> ;Multiple Sclerosis and Related Disorders. 2020 Aug 1
• 6 citations
  Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era.
  John Robert Ciotti, Elena Grebenciucova, Brandon P Moss, Scott D. Newsome> ;Annals of Neurology. 2020 Sep 30
• 5 citations
  Clinical instrument to retrospectively capture levels of EDSS.
  John Robert Ciotti, Noah Sanders, Amber Salter, Joseph R. Berger, Anne H. Cross, Salim Chahin> ;Multiple Sclerosis and Related Disorders. 2020 Apr 1
• 45 citations
  Disease-Modifying Treatment in Progressive Multiple Sclerosis.
  John Robert Ciotti, Anne H. Cross> ;Current Treatment Options in Neurology. 2018 Apr 7
• Join now to see all

Journal Articles

• Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica  
  Ciotti JR, Eby NS, Wu GF, Naismith RT, Chahin S, Cross AH, Multiple Sclerosis and Related Disorders, 7/13/2020
• Clinical instrument to retrospectively capture levels of EDSS  
  Ciotti JR, Sanders N, Salter A, Berger JR, Cross AH, Chahin S, Multiple Sclerosis and Related Disorders, 12/3/2019
• Disease-Modifying Treatment in Progressive Multiple Sclerosis  
  Ciotti JR, Cross AH, Current Treatment Options in Neurology, 4/7/2018